Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Ulrich-Merzenich (Bonn, Germany). Characterization of CD4-endotypes in severe allergic asthma for future precision medicine. 3553

Member's Comments

No comment yet.

Related content which might interest you: Characterisation of a chronic pre-clinical model of allergic asthma Source: International Congress 2018 – Studies on the mechanisms underlying airway disease Year: 2018 Anti-IgE treatment, airway inflammation and remodelling in severe allergic asthma: current knowledge and future perspectives Source: Eur Respir Rev 2015; 24: 594-601 Year: 2015 A novel evaluation of the impact of severe allergic asthma in children: The family perspective Source: Annual Congress 2010 - Quality of life, asthma control and monitoring childhood asthma Year: 2010 Effectiveness of omalizumab in improving quality of life in patients with ‘steroid-resistant‘ asthma and severe allergic rhinitis Source: Annual Congress 2012 - Clinical aspects and treatment of asthma and allergic respiratory diseases Year: 2012 Anti-IgE treatment: An alternative for severe allergic occupational asthma Source: Annual Congress 2012 - Asthma and COPD at work: what are the effects of exposure and risk factors? Year: 2012 Comparative analysis of allergic and non-allergic severe persistent asthma Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches Year: 2009 Development of an integrated allergic rhinitis and asthma model with partial immunological tolerance Source: Annual Congress 2009 - Animal models of airways inflammation Year: 2009 Specific immunotherapy in the management of allergic asthma Source: Annual Congress 2008 - PG2 - Asthma: natural history, risk factors and overall management Year: 2008 Efficacy of Omalizumab in adult and pediatric severe allergic asthma according to presence of multiple allergic comorbidities: evidence from the STELLAIR study. Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma Year: 2019 Translational strategy for allergic asthma Source: International Congress 2014 – Sadoul Lecture “From molecules and cells to phenotypes: deciphering chronic airways disease” followed by related presentations Year: 2014 Continuing allergic inflammation determines asthma chronicity in children Source: Eur Respir J 2006; 28: Suppl. 50, 850s Year: 2006 Utility of Interleukin-5 in phenotyping allergic versus non allergic asthma Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021 Component-resolved allergy diagnostics identify phenotypes in problematic severe childhood asthma Source: Annual Congress 2011 - Risk and detection of childhood asthma and allergy Year: 2011 Assessing severe asthma Source: Eur Respir J 2016; 48: 611-613 Year: 2016 The ERS/EAACI statement on severe exacerbations of asthma, and how to deal with non-allergic severe asthma Source: International Congress 2019 – Pathophysiology and clinical insights into severe non-allergic asthma Year: 2019 Practical use of control of allergic rhinitis and asthma test in a telehealth service Source: International Congress 2018 – Primary care management of respiratory conditions Year: 2018 Allergic rhinitis and coexistence of allergic rhinitis and asthma at Greek children. Comparison of clinical and laboratory pararameters Source: Eur Respir J 2006; 28: Suppl. 50, 255s Year: 2006 Evaluation in a severe asthma expert center improves asthma outcomes. Source: International Congress 2018 – New modalities in asthma treatment Year: 2018 Immunotherapy prevents the development of asthma in subjects with allergic rhinitis Source: Eur Respir J 2001; 18: Suppl. 33, 482s Year: 2001